Acquisitive pharmaceutical major Abbott Laboratories is adding another new asset to its portfolio. The company has agreed to acquire peer St. Jude Medical in cash and stock deal currently valued at roughly $25 billion. In its press release heralding the purchase, Abbott said that “St.